There is no universal minimum order quantity for a custom Zamak medical component. A practical MOQ is the smallest lot that covers the current program decision, the selected tooling and process setup, required validation samples, destructive tests, finish or assembly batch constraints, traceability and acceptable unit cost. Buyers should request separate quantities and prices for prototypes, tool trials, validation/pilot builds and repeat production.
State whether the order supports ergonomic review, engineering verification, design validation, process qualification, clinical or usability work, launch inventory, service spares or repeat commercial production. Each gate needs different material, process fidelity and records. A handful of appearance models cannot release a production die-cast medical housing.
List the samples consumed by dimensional studies, cleaning or sterilization exposure, drop, vibration, ingress, EMI, coating, mechanical cycling, destructive sectioning and retention tests. Include reserve samples, multiple cavities, process extremes and failures for investigation. The ordered quantity must cover evidence as well as assemblies.
Lot purpose | Manufacturing question | Why quantity varies |
|---|---|---|
Prototype | Does geometry, fit, balance or interface concept work? | May use a different process and cannot prove casting capability |
Tool trial | Do all cavities fill, eject and meet raw-casting needs? | Needs cavity samples plus correction and finish experiments |
Validation or pilot | Can the complete process and device meet requirements? | Includes conditioned, destructive and traceable samples |
Repeat production | Can demand be supplied at stable quality and cost? | Driven by setup, finish loads, assembly, packaging and forecast |
Rapid prototyping is useful when the current question does not require production Zamak or a production die. The drawing and report should identify material and process differences so prototype results are not overextended.
A die-cast order carries tool setup, machine setup, alloy preparation, first-off approval, trimming, process stabilization, inspection and lot documentation. Finishing may add rack, bath, paint-mix or cure-lot constraints. Machining adds fixtures and program setup; assembly adds incoming subcomponents, line setup and testing.
Ask which cost is fixed per run, per finish load, per cavity or per part. A supplier may technically make a small lot while the unit cost remains high. Combining unrelated medical parts in one order does not remove separate setup, traceability and cleaning requirements.
A multicavity tool needs enough identified pieces from every cavity to evaluate dimensions, appearance and function. Sampling only mixed pieces can hide a weak cavity. Include startup, stable-run and end-of-run intervals where the control plan requires them.
For coating, assembly and packaging, preserve links to casting lot and cavity. If testing uses minimum and maximum coating or tolerance stacks, order enough parts to select or deliberately produce those conditions. Validation quantity should come from the protocol and risk analysis, not an arbitrary percentage.
Medical programs can change after usability, electrical, sealing or regulatory review. Large early orders may trap obsolete housings, labels and custom inserts. Consider unfinished casting buffers only when storage, corrosion protection, later surface preparation, revision identification and demand justify them.
Use staged purchase releases, controlled safety stock and clear liability for obsolete inventory. Separate tool ownership from part MOQ. A lower piece price is not a saving if an unapproved revision cannot be used or reworked.
Gaskets, inserts, fasteners, labels, windows, grounding hardware and cartons may have their own supplier minimums. One long-lead custom item can set the practical assembly lot. Confirm shelf life for adhesives, coatings, elastomers and sterile or barrier packaging where applicable.
Packaging quantity should protect finished surfaces, cleanliness and traceability without creating excessive partial cartons or mixed revisions. Define whether parts ship as castings, finished housings, subassemblies or tested device modules.
A small medical lot still needs revision control, material linkage, inspection status, nonconformance disposition and shipment traceability. These activities do not shrink in direct proportion to piece count. Ask whether documentation, retained samples, first-article work and customer release are included in the quoted setup or charged separately.
Keep trial, validation and production lots physically and electronically distinct. A low quantity is useful only when affected parts can be identified after a test failure or design change. Mixing leftover trial pieces into commercial stock may undermine the evidence the small lot was intended to create.
Provide the same drawing, alloy, finish, inspection, validation support, documentation, assembly and packaging assumptions for each quantity break. Otherwise the cheapest quote may quietly remove testing or change the surface route. Ask for tool cost, setup cost, unit price, yield assumptions and lead-time drivers separately.
Moving zinc parts from prototype to production requires explicit gates. Do not use a production price break as the decision to release mass production.
The RFQ should state project phase, tool status, annual and release demand, variants, required cavities, validation sample matrix, destructive tests, alloy, finish, machining, assembly, traceability, reports, packaging, shelf life, service stock and forecast uncertainty. Ask the supplier to identify the minimum economical run for each process and the absolute technical minimum.
The best MOQ is therefore project-specific. It should be large enough to produce defensible evidence and stable processing, yet small enough to limit cost and obsolete-revision exposure before the device and manufacturing process are approved.